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Riassunto 
          
         Le cellule staminali embrionali (ESCs) sono cellule non 
specializzate capaci di auto-rigenerasi e differenziare in tutti i tipi 
cellulari di un organismo, mimando gli eventi che avvengono in vivo 
durante le prime fasi dello sviluppo. Per queste caratteristiche, una 
profonda conoscenza dei meccanismi che governano il destino delle 
ESC è fondamentale sia per la ricerca di base che per la terapia 
cellulare. Negli ultimi anni sono stati fatti enormi progressi nella 
comprensione della pluripotenza delle ESC, mentre i meccanismi che 
governano il destino delle ESC ed, in particolare, i meccanismi che 
governano l’uscita di queste cellule dallo stato basale di pluripotenza e 
le prime fasi del differenziamento, non sono stati ancora ben capiti. In 
questo contesto il nostro gruppo di ricerca ha sviluppato un approccio 
sistematico basato sullo screening di una libreria di shRNA per 
identificare fattori che governano il destino delle ESC. Tra i geni 
identificati abbiamo trovato il gene HMGA2, una proteina non 
istonica associta alla cromatina, ampiamente espresso durante lo 
sviluppo e che svolge un ruolo importante  nei processi di 
adesione/differenziamento cellulare. Abbiamo trovato che il 
knockdown di HMGA2 promuove il mantenimento di uno stato di 
pluripotenza. Infatti, in condizioni che promuovono il 
differenziamento, il knockdown di HMGA2 mantiene l’espressione 
dei marcatori di staminalità Oct3/4 e Nanog. Inoltre, abbiamo trovato 
che l’espressione dei marcatori di staminalità è accompagnata da una 
riduzione del marcatore del neuroectoderma Sox1. Un’analisi 
dettagliata del fenotipo indotto dalla soppressione di HMGA2, ha 
mostrato che il blocco del differenziamento avviene nelle prime fasi, 
ovvero nella transizione delle ESCs a cellule staminali dell’epiblasto 
(EpiSCs). Gli stessi effetti, accompagnati da un fenotipo molto più 
evidente, sono stati osservati in seguito all’induzione del 
differenziamento di cellule staminali pluripotenti indotte (iPS) knock 
out per HMGA2. Successivamente, abbiamo trovato che l’espressione 
di HMGA2 è regolata da un fattore trascrizionale (FT) chiave Otx2, 
che da solo o in combinazione con Oct4 guida l’attivazione di 
enhancer precoci durante l’uscita delle ESC dallo stato basale verso la 
la formazione dell’epiblasto. Inoltre, abbiamo osservato che HMGA2 
coopera con Otx2 nella formazione di enhanceosomi. In conclusione, i 
risulati ottenuti durante la mia tesi di dottorato, dimostrano che 
HMGA2 agisce prendendo parte ai meccanismi di regolazione che 
guidano l’uscita delle ESCs dallo stato basale di pluripotenza.  
Summary 
 
       Embryonic stem cells (ESCs) are non-specialized cells able to 
self-renew and to differentiate in vitro giving rise to all cell types of 
an organism, mimicking the events that take place in vivo during the 
early stages of the development. For these characteristics, a deep 
knowledge of the mechanisms that govern ESC fate is fundamental 
for both basic research and cell replacement therapy. In the recent 
years, enormous progresses have been made in the understanding of 
ESC pluripotency, while the mechanisms governing the ESC 
differentiation and, in particular, the mechanisms governing the exit 
from the pluripotent state and the first steps of differentiation are still 
not definitively understood. In this context, our group has developed a 
systematic approach based on the screening of a shRNA library to 
identify factors governing ESC fate. Among the identified genes, we 
have found the high mobility group AT-hook 2 (HMGA2), a non-
histone chromatin factor that is widely expressed during 
embryogenesis and is known to have important roles in development 
and cell adhesion/differentiation processes. We have found that the 
knockdown of HMGA2 promotes the maintenance of pluripotent 
state. Indeed, in conditions promoting differentiation, HMGA2 knock-
down cells maintain the expression of stemness markers Oct3/4, 
Nanog. Interestingly, we have found that the expression of stemness 
markers is accompanied by a decrease of neuro-ectodermal marker 
Sox1.  A more detailed analysis of the phenotype induced by HMGA2 
suppression has shown that the block of differentiation occurs during 
first steps, i.e. the transition from ESCs to epiblast stem cells 
(EpiSCs). The same effects, accompanied by a more dramatic 
phenotype, were observed upon differentiation of induced pluripotent 
stem cells (iPS cells) knock-out for HMGA2. We have found that 
HMGA2 expression is regulated by a key transcription factor Otx2 
that alone or in combination with Oct4 drives early enhancer 
activation during the exit from ground state of ESCs to EpiSCs. 
Indeed, we have shown that HMGA2 cooperates with Otx2 in 
enhanceosome formation. Finally, the results obtained during my 
doctoral thesis have demonstrated that HMGA2 acts taking part to the 
regulatory mechanisms that guide the exit of ESCs from ground state.  
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1. Introduction 
 
             Embryonic Stem Cells (ESCs) are primitive cells that have the 
remarkable capacity to self-renew and differentiate in vitro in all 
specialized cell types of an organism, thus mimicking the events that 
take place in vivo during the early stages of development. They were 
first derived from the inner cell mass (ICM) of blastocyst-stage 
embryos in 1981 (Evans and Kaufman 1981). The blastocyst is a 
vesicular structure comprising two cell types: the inner cell mass 
(ICM), a cluster of approximately 20 cells, adhering to one side of the 
vescicle and of an epithelial outer layer, the trophectoderm (TE), 
enclosing a fluid filled space. After the embryo has implanted in the 
uterus, the trophectoderm overlying the ICM proliferates (Rossant and 
Cross 2001) and grows into a thick column of extraembryonic 
ectoderm (ExE), which extends into the blastocoel and carries a 
compact epiblast at its distal pole. The embryonic epiblast is 
composed of a single layer of pseudostratified epithelia called 
primitive ectoderm, which gives rise to all three embryonic germ 
layers (ectoderm, mesoderm and definitive endoderm) and primordial 
germ cells (Pfister, Steiner et al. 2007). All these steps of 
embryogenesis can be recapitulated by ESCs because they express 
different sets of genes that, changing their expression level, drive the 
events of embryogenesis. The ESCs exhibit two remarkable features 
in culture: i) under appropriate conditions, they can be propagated 
indefinitely as a stable self-renewing population by retaining stem-cell 
identity; this characteristic allows ESCs to be cultured over extended 
periods; ii) ESCs under appropriate conditions and after removal of 
factors that maintain ESCs in undifferentiated state, can generate 
progeny consisting of derivatives of the three embryonic germ layers: 
ectoderm, endoderm and mesoderm, (Keller 1995) (Figure1).  
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Figure1: Embryo development: Pluripotent cells are stained in green. The 
inner part of the morula (A) forms the inner cell mass (ICM) of the 
blastocyst (B). The blastocyst is composed by two different cell types: the 
Inner cell mass (ICM) and the trophoectoderm. The ICM contains 
pluripotent cells which will give rise to all cells of the embryo. Thus, ES 
cells are isolated from ICM. In the late blastocyst (C) the ICM gives rise to 
primitive endoderm (Gata6 positive cells) and to the epiblast (Oct4 and 
Nanog positive cells). The primitive ectoderm origins from the epiblast. 
When gastrulation occurs (D), primitive ectoderm gives rise to three germ 
layers: ectoderm, mesoderm and endoderm From: (Niwa 2007) 
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It seems that there is no intrinsic limitation to the ability of ESCs to 
differentiate in vitro and ESC progeny can express appropriate 
markers and functional characteristic of specific cell sub-types, such 
as neurons or cardiomyocytes (Maltsev, Rohwedel et al. 1993; 
Strubing, Ahnert-Hilger et al. 1995; Lee, Hart et al. 2004). For these 
characteristics, nowadays, the ESCs are widely used for different 
purposes including gene targeting, cell therapy, tissue repair, organ 
generation and so on. They represent a major advance in biology and 
experimental medicine, so the understanding of the mechanisms 
underlying ESC differentiation is necessary to provide new ESC-
based developmental models and for clinical applications of cell 
therapy. The ESC stemness maintenance is supported by 
transcriptional and post-transcriptional mechanisms. The 
transcriptional mechanisms include both the responsiveness to 
external stimuli that activate the main pathways involved in stemness 
maintenance (Xiao et al., 2006; Ying et al., 2003), and the regulation 
of the expression levels of the “stemness transcription factors” such as 
Oct3/4, Sox2, Nanog, Stat3 and Klfs (Yuan et al., 1995; Nichols et al., 
1998). On the other hand, post transcriptional regulation of gene 
expression by microRNA is also important in the maintenance of 
stemness.  
 
 
1.1  LIF pathway is the main signal that modulate ESCs state 
 
              During self-renewal, ESC pluripotency is maintained through 
the balance between prevention of differentiation and promotion of 
proliferation. LIF (Leukemia inhibitory factor), a member of the IL-6 
family of cytokines, is a key factor that sustains pluripotency and 
prevents differentiation (Smith et al. 1988). LIF stimulates ESCs 
through the receptor gp130, which works as heterodimer together with 
LIF-Receptor. This activated complex signals the induction of Janus-
associated tyrosine kinase (JAK) and the signal transducer and 
activation of transcription (STAT). Activated STAT3 translocates into 
the nucleus and induces the expression of important genes involved in 
the stemness and pluripotency, such as the Kruppel like factors (Klfs), 
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Myc and Sall4 (Cartwright et al., 2005; Niwa et al., 2009). Therefore, 
STAT3 activation represents a crucial point in the maintenance of 
ESC stemness and its activation is sufficient to prevent ESC 
differentiation in presence of serum (Niwa et al., 1998). In addition to 
STAT3 activation, LIF also induces the phosphorylation of 
extracellular signal-regulated protein kinases, ERK1 and ERK2 and 
increases the mitogen-activated protein kinase (MAPK), which 
promotes differentiation (Matsuda, Nakamura et al. 1999). 
Proliferation, survival and maintenance of pluripotency in ESCs, are 
sustained also by the Phosphoinositide 3-kinase (PI3K)/Akt pathway 
(Takahashi, Murakami et al. 2005). LIF/PI3K pathways may act by 
activating a protein kinase B/glucocorticoid-inducible kinase SGK 
which inactivates glycogen synthase kinase (GSK)-3 in vitro. 
Inhibition of GSK-3 activity is known to facilitate self-renewal of 
mouse ES cells. Recent paper showed that the inhibition of GSK3 and 
MEK (mitogen-activated protein kinase/ERK kinase), through small-
molecules inhibitors (2i), is critical to establish and sustain ES cells 
(Wray et al., 2011) (Figure 1.1). Similarly, the Nodal/Activin pathway 
is crucial in ESCs. These proteins are present in various tissues and 
have a broad range of activities including the proliferation and 
differentiation of ESCs (Kunihiro Tsuchida et al.,2009) but, in this 
process, their role is still not clear. Some papers suggested a possible 
function of Nodal in the maintenance of ESC phenotype on the basis 
of the finding that Nodal-deficient mice show embryonic lethality due 
to a defective maturation of the ICM into epiblast with very low levels 
of Oct3/4 expression (Mesnard et al., 2006). Indeed, it has been 
demonstrated that Nodal/Activin signalling directly controls the Oct4 
expression in ESCs through Smad2 (Lee et al., 2011). 
 
Introduction 
 
5 
 
 
 
Figue 1.1:  Pathways required for maintaining pluripotency of ESCs. 
LIF signaling activates JAK-STAT3 to induce the expression of target 
genes crucial for pluripotency, such as c-myc. LIF also induces MAP 
kinase activation, that promotes differentiation. Activin/Nodal has 
been shown to contribute to ESC proliferation but not to pluripotency 
(Taken from Ohtsuka 2008 and modified). 
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1.2 Transcription factors 
    Self-renewal and pluripotency are maintained by perfectly 
balancing the expression of many transcription factors that act in a 
complex network (Niwa, et al .,2005). This network includes, in 
addition to the already mentioned STAT3, the homeodomain 
transcription factor Oct4 (Niwa et al., 2000), the variant homeodomain 
transcription factor Nanog (Chambers et al., 2003), the high mobility 
group (HMG)–box transcription factor Sox2 (Avilion et al., 2003) and 
the Kruppel-like factors (Klfs) (Jiang et al., 2008; Parisi et al. 2008) 
that are expressed specifically in pluripotent cells. 
Oct3/4: Oct3/4 is highly expressed in ESCs and its expression 
quickly decreases when differentiation occurs. Oct3/4 is a POU 
domain-containing transcription factor that binds to an octamer 
sequence and acts by preventing ESC differentiation (Nichols et al., 
1998). Oct3/4 has been reported to directly prevent differentiation 
towards trophectoderm by interacting with Cdx2 (a prominent gene 
for trophectoderm differentiation), to form a repressor complex (Niwa, 
Toyooka et al. 2005). Indeed, Oct3/4 suppression in undifferentiated 
ESC leads to an unappropriated differentiation into trophectoderm. On 
the other hand, Oct3/4 overexpression induces the differentiation into 
primitive endoderm (Niwa et al., 1998; Niwa et al., 2000), thus 
indicating that a tight control of this gene is crucial to maintain ESC 
undifferentiated state. 
Nanog: Nanog is a homeobox-containing transcription factor 
with an essential role in maintaining the pluripotent cells of the ICM 
in vivo and ESCs in vitro. It is highly expressed in pluripotent cells 
and absent in differentiated cells (Chambers et al., 2003).  Chambers 
and co-authors showed that Nanog KO ESCs can survive and 
proliferate by maintaining at least in part their undifferentiated state 
but with a marked tendency to differentiate into primitive endoderm 
(Chambers et al. 2007). It has been proposed that Nanog regulates 
pluripotency working as a transcriptional repressor of differentiation 
genes such as GATA4 and GATA6 (Chambers et al., 2007). However, 
Nanog can also activate genes necessary for self-renewal such as Rex1 
and Oct3/4 (Pan, Li et al. 2006). The function of Nanog might not be 
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restricted to prevent the differentation of ESCs into primitive 
endoderm but it can also block neuronal differentiation induced by the 
removal of LIF and BMPs from serum-free culture (Ying, Nichols et 
al. 2003). In addition, Nanog can also control mesoderm specification 
by repressing Brachyury, which encodes the mesoderm-specific T-box 
transcription factor T (Suzuki, Raya et al. 2006).  
Sox2: Sox2 is a transcription factor that plays an important 
role in the maintenance of pluripotent transcription factor network. 
Sox2 is known to co-operate with Oct3/4 in activating Oct3/4 target 
genes (Yuan, Corbi et al. 1995). Some papers have demonstrated that 
there are ESC-specific enhancers that contain binding sites for Oct3/4 
and Sox2, including those present in Nanog (Boyer, Lee et al. 2005; 
Kuroda, Tada et al. 2005; Rodda, Chew et al. 2005) and Rex1 genes, 
that, in turn, is also directly regulated by Nanog (Shi, Wang et al. 
2006). Interestingly, both Oct3/4 and Sox2 genes possess enhancers 
that are activated by Oct3/4-Sox2 complex in a stem-cell-specific 
manner (Tomioka, Nishimoto et al. 2002; Chew, Loh et al. 2005; 
Okumura-Nakanishi, Saito et al. 2005). Thus, an alteration of Sox2 
expression levels in ESCs induces uncontrolled differentiation with 
the same phenotype observed for Oct3/4 misregulation (Ivanova et al., 
2006). Recent studies have enabled to integrate all these key 
transcription factors, in an intrinsic core-regulatory circuit that 
maintains ESCs in the pluripotent state in vitro (Figure 1.2). 
             Klfs: In recent years  the crucial role of Kruppel-like factor 
(Klf) family in the ESCs has been studied. Klfs are zinc finger 
transcription factors that regulate many biological processes, including 
proliferation, differentiation, development and apoptosis (McConnell 
et al., 2007). It has been demonstrated that Klf2, Klf4 and Klf5 have 
an ESC-specific expression with high levels of transcripts in 
undifferentiated ESCs, that drastically decrease when differentiation 
occurs (Jiang et al., 2008; Parisi et al., 2008). Klfs have also a crucial 
role in reprogramming of somatic cells. Indeed, Klf4 is one of the four 
transcription factors used to induce somatic cell reprogramming 
(Takahashi and Yamanaka, 2006). Moreover, Nakagawa et al. have 
demonstrated that Klf2 and Klf5 could replace Klf4 in ‘Yamanaka 
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cocktail’ to induce reprogramming (Nakagawa et al., 2008). In Klfs 
family, Klf5 is emerged to have a key role during blastocyct 
development in vivo as well as in ESC stemness in vitro. In fact, Klf5 
works by activating  self-renewal promoting genes and, at the same 
time, by inhibiting the expression of differentiation-related genes 
(Parisi et al., 2010). Klf5 suppression induces an aberrant 
differentiation of ESCs also in undifferentiated culture conditions 
(Ema et al., 2008; Parisi et al., 2008). In addition, it has been shown 
that Klf5 ectopic expression is able to sustain stemness also in 
differentiating conditions (Parisi et al., 2008; Ema et al., 2008), thus 
demonstrating the crucial role of Klf5 in ESCs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: A transcription factor network controlling ESC self-
renewal and differentiation. Transcription factor network in 
pluripotent ESCs. Positive-feedback loops between Oct3/4, Sox2 and 
Nanog maintain their expression and promote continuous ESC self-
renewal (Adapted by Niwa 2007).  
NanogOct3/4:Sox2
Oct3/4 Sox2
Key
activation
interaction
Pluripotent stem cell
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1.3 Epiblast Stem Cells (EpiSCs) 
               Epiblast Stem Cells (EpiSCs) are pluripotent cells isolated 
from post-implantation embryos. EpiSCs recapitulate the defining 
properties of their in vivo tissue of origin (Baoet al., 2009; Brons et 
al., 2007; Guo et al., 2009; Tesar et al., 2007) and are capable to 
differentiate into cell types of all three embryonic germ layers as well 
as the germ lineage in vitro (Aoki et al., 2009; Hayashi and Surani, 
2009; Tesar et al., 2007; Vallier et al., 2009). They can be expanded 
indefinitely in culture being maintained in an undifferentiated state by 
activin/Nodal and FGF signaling pathways which, when inhibited, 
rapidly induce EpiSCs differentiation into neurectodermal lineage 
(Brons et al., 2007; Guo et al., 2009; Tesar et al., 2007). The 
regulation of Activin/Nodal pathway is a distinguishing characteristic 
of the mouse ESC and EpiSCs states. Indeed Oct4, Nanog, and Sox2 
are expressed at lower level in EpiSCs than in ESCs, while Fgf5 and 
Brachyury are exclusive markers of Epiblast state (Hanna et al., 2010; 
Lanner and Rossant 2010). Some papers showed that EpiSCs share 
defining features with human ESCs which are derived from human 
pre implantation embryos (Brons et all., 2007; Tesar et all., 2007), 
including gene expression profile and epigenetic status. Based on this 
observation it seems that EpiSCs and human ESCs are in a ‘’primed’’ 
state on the road to differentiation, while mouse ESCs are in a naïve, 
more primitive state (Nichols and Smith, 2009). However, Najm et al., 
and Tesar et al., demonstrated that mouse blastocysts can also give 
rise to EpiSCs. Utilizing modified derivation protocol, without 
exogenous growth factors such as LIF, FGF2 or activin, the authors 
derived ESC lines from blastocysts from non-permissive strains of 
mice. This suggested that the type of pluripotent cell lines that are 
most readily derived from blastocysts  is a primed EpiSC-like cell 
line. Recently, numerous studies have revealed that the ESC state is 
maintained by a dynamic mechanism characterized by reversible 
differences in the sensitivity to self-renewal and susceptibility to 
differentiation of ES cells population. This behavior is named 
‘’metastable condition’’ that ensure indefinite self-renewal and at the 
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same time predisposes ESCs to EpiSC differentiation . These works 
demonstrated that a crucial role in this mechanisms is played by Otx2, 
a transcription factor essential for multiple steps of brain development 
and neuronal differentiation (Simeone et al., 1992; Simeone et al., 
2002; Simeone et al., 2011). Otx2 antagonizes ground state 
pluripotency and promotes commitment to differentiation. It is 
required for ESC transition into EpiSCs and, subsequentely, to 
stabilize the EpiSC state by suppressing the switch of mesendoderm to 
neural fate in cooperation with Bmp4 and Fgf2. However to govern 
precisely the differentiation towards a specific fate, it is important to 
understand the molecular mechanisms that regulate pluripotent cell 
self-renewal and differentiation. For this reason we performed a 
screening of a shRNA library to identify factors governing ESC fate. 
Among these factors we found HMGA2.  
 
 
1.4 The High Mobility Group (HMG) factors 
 
              The high mobility group (HMG) proteins are abundant, 
heterogeneous, non-histone components of chromatin that lack a 
transcriptional activity per se, but act by orchestrating the assembly of 
transcription factors complexes, thus resulting in a positive or 
negative regulation of gene expression (Wolffe et al., 1994; Ashar et 
al., 2010). The members of the HMGA family of proteins, HMGA1 
(HMGA1a and HMGA1b, HMGA1c) and HMGA2, contain three N-
terminal “AT-hook” motifs, through which they bind preferentially to 
AT-rich sequences, and induce conformational changes to promote the 
recruitment of transcription factors to specific complexes. HMGA 
members are highly expressed during embryogenesis; their expression 
becomes more restricted as fetal development progresses with low or 
undetectable expression in adult (Zhou et al., 1995; Chiappetta et al., 
1996) and becomes abundant in malignant cells in vitro and in vivo, 
where they have been extensively studied (Fusco and Fedele, 2007).  
The high expression of HMGA proteins during embryogenesis 
suggests that they fulfill important roles in development. Indeed, the 
phenotypic characterization of mice knocked out (KO) for each of the 
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HMGA genes revealed that these proteins play crucial roles in 
development (Fusco and Fedele, 2007), indeed it has been recently 
reported that the HMGA1/HMGA2 double KO mice show embryonic 
lethality (Federico et al., 2014). However, the physiological role of 
HMGA factors in the early steps of development is still unknown as 
well as the transcription regulatory mechanisms they are involved in. 
 
    
1.5 Mechanisms of action of HMGA proteins  
 
             HMGA protein group favors the formation of multi-subunit 
protein-DNA complexes by modifying chromatin structure. The 
mechanisms of action of HMGA proteins could be summarized in: 
1. Macromolecular complexe formation in which HMGA directly bind 
to DNA on AT-rich sequences, modify its conformation and facilitate 
the binding of transcription factors on their own consensus sequences, 
as in the best studied case of human β-interferon gene (IFN-β) 
(Thanos and Maniastis, 1992). 
2. Protein -protein interactions with transcription factors inducing 
changes in their DNA binding affinities; for example HMGA2, can 
interact with the transcriptional repressor p120E4F and this interaction 
results in disruption of p120E4F binding to the cAMP response 
element (CRE) site of the cyclin A gene promoter and subsequent 
activation of cyclin A gene transcription (Tessari et al., 2003).  
3.Chromatin remodeling. In this context, the highly AT-rich 
sequences have high affinity for the nuclear matrix and organize 
genomic DNA into topologically distinct loop domains that are 
important in transcription (Saitoh and Laemmli, 1994). So, HMGA is 
involved in the dynamic changes of chromatin structure playing a 
dominant role in the regulation of gene transcription. 
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Figure 1.5: Mechanisms of action of HMGA proteins. a) HMGA 
proteins can modulate or assemble macromolecular complexes 
directly binding to the DNA. In doing so, HMGA proteins modify 
DNA conformation facilitating the binding of transcription factors 
(TF). b) HMGA proteins also influence gene expression through 
direct protein-protein interaction with TF inducing changes in their 
DNA-binding affinity. c) HMGA proteins have the ability to alter 
chromatin structure. (Fusco and Fedele, 2007). 
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1.6 Scientific hypothesis and aim of the work 
 
               The deep knowledge of the mechanisms that govern ESC 
fate is fundamental for both basic research and cell replacement 
therapy. As mentioned above, in this context some years ago we 
developed a systematic approach based on the screening of a shRNA 
library to identify factors governing ESC fate. HMGA2 was found 
among the genes whose suppression impairs ESC differentiation. 
These preliminary results, together with the consideration that 
HMGA2 is a chromatin remodeler and as such a regulator of gene 
expression, indicated that HMGA2 might have a crucial role in the 
control of ESC differentiation. Thus, the main aim of my thesis was 
the identification and characterization of HMGA2 role in governing 
ESC fate. To reach this aim I have addressed the following tasks: 
- analysis of the expression profile of Hmga2 in undifferentiated 
ESCs and during differentiation; 
- characterization of the phenotype due to the suppression 
(silencing) or the absence (iPS cells KO for HMGA2) of 
HMGA2 in the regulation of pluripotent stem cell fate; 
- identification of the genes influenced by the chromatin 
remodeling activity of HMGA2; 
- identification of the genes controlling HMGA2 expression.   
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2. Materials and Methods  
 
2.1 ESC culture, monolayer differentiation and transfection 
              E14Tg2a (BayGenomics) mouse ESCs were maintained on 
feeder-free gelatine-coated plates in the following medium (ESC 
medium): GMEM (Sigma) supplemented with 2mM glutamine 
(Invitrogen), 100U/ml penicillin/streptomycin (Invitrogen), 1mM 
sodium pyruvate (Invitrogen), 1x non-essential amino acids 
(Invitrogen), 0.1 mM -mercaptoethanol (Sigma), 10% FBS 
(Hyclone) and 10
3
 U/ml leukemia inhibitory factor (LIF) (Euroclone).  
For monolayer differentiation, ESCs were trypsinized into a single 
cells suspension, collected by centrifugation and resuspended in the 
following differentiation medium: Knockout Dulbecco’s minimal 
essential medium supplemented with 10% Knockout Serum 
Replacement (both from Invitrogen), 0.1 mM β-mercaptoethanol 
(Sigma), 2 mM glutamine (Invitrogen), 100 U/mL 
penicillin/streptomycin (Invitrogen). Then, the cells were plated at low 
density (3x10
3
 cells/cm
2
) on gelatin-coated dishes and differentiation 
medium was changed on alternated days. 
For transfection ESCs were plated at 6x10
4
 cells/cm
2
 the day before 
the transfection. The transfection was performed by using 
Lipofectamine 2000 (Invitrogen) with siRNAs (Invitrogen) following 
manifacturer’s instructions. 
 
2.2 SFEBs differentiation and generation of EpiSCs 
 
              ESC differentiation into neuroectoderm was induced though 
SFEB formation. SFEBs were induced by placing 1x10
6
 ESCs in 100-
mm Petri dishes in the followingdifferentiation medium: GMEM 
supplemented with 2 mM glutamine, 1 mM sodiumpyruvate, 1 × 
nonessential amino acids, 0.1 mM β-mercaptoethanol and 10% KSR. 
The formation of EpiSCs was induced adapting the methods of 
Hayashi et al., and Nakaki et al. In brief, ESCs were dissociated into a 
single-cell suspension with 0.05%Trypsin-EDTA at 37 °C for 5 min. 
Individual cells were then seeded in fibronectin-coated dishes at a 
density of 2.5x10
5 
cells/cm2 in ESC culture condition, and after 18 h 
Materials and Methods 
 
15 
 
the medium was switched to the following EpiSC medium: 1 vol of 
DMEM/F12 combined with1 vol of Neurobasal medium, 
supplemented with 0.5% N2 supplement, 1% B27supplement, 1% 
KSR, 2 mM glutamine (Invitrogen), 20 ng/ml Activin A (R&D 
Systems),and 12 ng/ml bFGF (Invitrogen). Within 2 days in these 
conditions the cells undergo morphological transformation (including 
flattening, diminished cell-cell interactions and formation of cellular 
protrusions) and express epiblast markers. 
 
2.3 RNA extraction, retro-transcription and real time PCR 
 
            Total RNA was extracted by using TRI-Reagent (Sigma). The 
first-strand cDNA was synthesized according to the manufacturer’s 
instructions (M-MLV RT kit; New England Biolabs). Real Time RT-
PCR was carried out with QuantStudio 7 Flex (Applied Biosystems) 
using Power SYBR Green PCR Master mix (Applied Biosystems). 
The housekeeping GAPDH mRNA was used as an internal standard 
for normalization, using 2
-∆Ct
 method. Gene specific primers used for 
amplification are: 
Oct3/4-f: 5’-AACCTTCAGGAGATATGCAAATCG-3’ 
Oct3/4-r: 5’-TTCTCAATGCTAGTTCGCTTTCTCT-3’ 
Nanog-f: 5’- TCAGAAGGGCTCAGCACCA-3’ 
Nanog-r: 5’- GCGTTCACCAGATAGCCCTG-3’ 
Rex1-f: 5’- GCAGTTTCTTCTTGGGATTTCAG-3’ 
Rex1-r: 5’- CTAATGCCCACAGCGAT-3’ 
Dax1-f: 5’- AGATGGAGAAAGCGGTCGTA-3’ 
Dax1-r: 5’- AAGCCAGTATGGAGCAGAGG-3’ 
Klf4-f: 5’- ACTCACACAGGCGAGAAACCTTAC-3’ 
Klf4-r: 5’- TCAGTTCATCGGAGCGGG-3’ 
Gapdh-f: 5’-GTATGACTCCACTCACGGCAA-3’ 
Gapdh-r: 5’-TTCCCATTCTCGGCCTTG-3’ 
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2.4 Antibodies and western Blot analysis 
 
              Undifferentiated and differentiated ESCs were lysed in a 
buffer containing 1 mM EDTA, 50 mM Tris-HCl (pH 7.5), 
70mMNaCl, 1% Triton and protease inhibitor cocktail (Sigma), and 
analyzed bywestern blot. The following primary antibodies were used: 
mouse Oct3/4 (1 : 2000 Santa Cruz Biotechnology), rabbit Nanog (1 : 
1000 Calbiochem-EMD Biosciences, La Jolla, CA, USA) mouse 
GAPDH (1 : 1000 Santa Cruz Biotechnology), goat Sox1 (1 : 100 
Santa Cruz Biotechnology), rabbit Otx2 (1 : 500 Abcam) rabbit 
HMGA2 (1: 500 Cell Signaling) ; HMGA2 (1:500 antibody provided 
by  A.Fusco et al.,). Antibody protein complexes were detected by 
HRP-conjugated antibodiesand ECL (both from Amersham 
Pharmacia, Milan, Italy). 
 
 
2.5 Immunofluorescence  
 
            Undifferentiated or monolayer differentiated ESCs were fixed 
in 4% paraformaldehyde and permeabilized with 0.2% TX-100 in 
10% FBS /1% BSA in 1X PBS for 15 min at room temperature. Thus 
the samples were incubated primary antibody. Following primary 
antibodies incubation, cells were incubated with appropriate 
secondary antibodies .  
SFEBs were washed once with PBS 1  and fixed in 4% 
paraformaldehyde over night at 4°C with gentle rotation. The next two 
days dehydration was performed with increasing percentage of EtOH. 
The fourth day after one wash in Toluene for 40’ at RT the samples 
were included in paraffin blocks. IF on slices was performed 
following a standard protocol.  Briefly, the slides were washed two 
times in Xilene at RT for 3’ and then rehydrated with a series of  
washes in EtOH at decreasing percentage.  Then permeabilization was 
performed with 0.2% TX-100 for 5’ followed by 2 washes in 1x PBS 
for 2’. Then, unmasking was performed in Citrate Buffer 1x. The non-
specific block was performed by treating in 10% FBS/1% BSA/0.1% 
Tween 20/ 1x PBS for 2-3h at RT followed by primary antibodies 
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incubation, washes and secondary antibody hybridization. Nuclei were 
counterstained with Dapi (Calbiochem). The following primary 
antibodies were used: anti Oct3/4 (1:200, Santa Cruz), anti-βIII-
tubulin (1:400, Santa Cruz) and anti-Sox1 (1:100, Santa Cruz). The 
secondary antibodies used are: anti-mouse Alexa 594 and anti-goat 
Alexa 488 (1:400, Molecular Probes). Images were captured with an 
inverted microscope (DMI4000, Leica Microsystems) or with a 
confocal microscope (LSM 510 META, Zeiss). 
 
 
2.6 Chromatin immunoprecipitation (ChIP)-qPCR analysis 
             For ChIP-qPCRanalysis, ESCs untrated, differentiating 
EpiSCs and SFEBs  were cross-linked with 1% formaldehyde for 10 
min at room temperature and then with125 mM glycine. The 
chromatin was then sonicated to an average DNA fragment length of 
500–1000 bp. Soluble chromatin extracts were immune-precipitated 
using an anti-Oct4 (Santa Cruz Biotechnilogy), anti-Otx2 (Millipore) 
anti-HMGA2 (Cell Signaling) antibody. Appropriate IgGs were used 
as negative control. Supernatant obtained without an antibody was 
used as an input control. After qPCR, the amount of precipitated DNA 
was calculated relatively to the total input chromatin and expressed as 
percentage of total chromatin or as fold enrichment relative to 
untreated samples. Oligonucleotide pairs are: 
Oct3/4-f: 5’-CTGGCCAGTGAGTCACCAAA-3’ 
Oct3/4-r:  5’-AAGTATGCCTGCAGCCCAG-3’ 
HMGA2-f: 5’-TGGTCCTTTTGCAGACTGGAT-3’ 
HMGA2-r: 5-‘GCACTGGTATTCACAACTGCC-3’ 
CR4-f:5’- GGAACTGGGTGTGGGGAGGTTGTA-3’ 
CR4-r:5’-AGCAGATTAAGGAAGGGCTAGGACGAGAG-3’ 
Otx2-f: 5’- TCAAGACCGCAAACTGCTCA-3’ 
Otx2-r:5’- TCAAGACCGCAAACTGCTCA-3’ 
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2.7 iPS generation and culture 
 
            The formation of iPS wt e HMGA2 KO was induced adapting 
the methods of Nakagawa et al., 2007. In brief, Mouse pMXs-based 
retroviral vectors for Oct4, Sox2 and Klf4 were transfected into Plat-E 
cells plated to 4.5x10
6
 cells per 10 cm
2
 dishes by using Lipofectamine 
2000 (Invitrogen) following manifacturer’s instructions.Twenty-four 
hours after transfection, the medium was replaced. Virus-containing 
supernatant was mixed with ratio of 1:1:1 and incubated in the 
virus/polybrene (8μg/ml) for 24 hours on Plat-E. MEFs wt e KO 
HMGA2 were plated 2x10
5
 cells per 9,6 cm
2 
 well and infected for 
twice with TFs transduced virus mix. After 24 hours from second 
infection, each well MEFs was split in 10 cm
2 
plate in DMEM 
(Sigma) combined with 2 mM glutamine (Invitrogen). The next day 
medium were changed with ESC medium condition contained 15% 
FBS (Hyclone). The medium was change every 2 days. To 21
th 
day, 
appeared iPS clones were picked and seeded in 2 cm
2 
 well on 
mytomicin treated MEFs. Obtained wt and HMGA2 KO iPS clones 
were maintained on feeder-gelatine-coated plates in the following 
medium (iPS medium): Glasgow Minimal Essential Medium (GMEM 
Sigma) supplemented with 2mM glutamine (Invitrogen), 100U/ml 
penicillin/streptomycin (Invitrogen), 1mM sodium pyruvate 
(Invitrogen), 1x non-essential amino acids (Invitrogen), 0.1 mM -
mercaptoethanol (Sigma), 15% FBS (Hyclone), 10
3
 U/ml leukemia 
inhibitory factor (LIF) (Euroclone), and 2i (MEK and GSK3 
inhibitors) PD0325901 3μΜ and CHIR-99021 1μM (Selleckchem) 
respectively. 
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3. Results 
 
3.1 Hmga2 suppression hampers mESCs differentiation 
 
              The screening of a shRNA collection, designed to target as 
many as possible mouse genes, allowed the identification of many 
genes whose suppression impairs ESC differentiation (Aloia et 
al.,2010). Among these genes we found HMGA2. Two shRNAs of 
our RNAi collection, targeting the HMGA2 mRNA, hampered the 
differentiation process of ESCs. The block of neuronal differentiation 
due to HMGA2 suppression was very evident when ESCs, transfected 
with specific shRNAs targeting HMGA2 mRNA, were differentiated 
in monolayer culture (Figure 3.1.1). 
 
 
 
 
Figure 3.1.1: The effect of HMGA2 suppression. Staining with β3-
tubulin antibody in the ESC transfected with two independent 
shRNAs targeting HMGA2 and induced to differentiate into neurons. 
The presence of post-mitotic neurons was detected by immunostaining 
with the antibody for βIII tubulin at 7 days of differentiation.  
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The evident effect of HMGA2 suppression on ESC differentiation was 
confirmed in a second experimental setting, that is serum free 
embryoid bodies (SFEBs). In the absence of serum, ESCs aggregate to 
form bodies starting to express neural-specific markers, like Sox1, 
around day 2 of differentiation. As shown in figure 3.1.2, the inner 
part of the SFEBs contains small groups of cells still positive for the 
stemness markers, like Oct4 and Nanog. The silencing of HGMA2 by 
siRNAs resulted in a decrease of Sox1 positive cells and an increase 
of the cells still positive for pluripotency markers at 4 days of SFEB 
differentiation. 
 
 
 
 
Figure 3.1.2: HMGA2 silencing hampers ESC differentiation. 
ESCs transfected with siRNA Hmga2 and siNS were induced to 
differentiate as SFEB and after 4 days the presence of stemness 
(Oct3/4) and neuroectodermal (Sox1) markers was analyzed by 
immune-staining. 
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HMGA2 protein was not detectable in undifferentiated ESCs but it 
appeared soon after the induction of differentiation (day 2, 
corresponding to the epiblast stage), accumulated up to day 4 and 
disappeared with the development of post-mitotic neurons (day 7). In 
this differentiation condition, Oct4 levels rapidly declined, becoming 
actually undetectable at day 4, while Otx2 was strongly induced at day 
2 and maintained elevated levels of expression up to day 7 (Figure3 
1.3). 
 
 
 
 
 
 
Figure 3.1.3: Expression profile of HMGA2, Oct4 and Otx2 
during ESC differentiation. Western blot analysis shows a time 
course of endogenous protein expression for HMGA2 compared with 
Oct4 and Otx2 protein trend during ESC differentiation. 
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The expression profile of HMGA2 KD cells induced to differentiate 
into SFEBs was significantly different. The protein levels of Oct4 was 
maintained at higher levels up to day 4, while Otx2 protein did not 
significantly change (Figure 3.1.4A). Rex1 and Klf4, specific markers 
of undifferentiated ESCs, was turned off, as soon as ESCs 
differentiated. These genes were expressed at very low levels in 
control-transfected SFEBs, whereas their expression resulted 
significantly high in SFEBs derived from HMGA2 KD ESCs (Figure 
3.1.4B). These results suggested that the suppression of HMGA2 may 
hamper the first step of ESC differentiation: the transition from ESCs 
into EpiSCs.  
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A 
 
B) 
 
 
 
 
Figure 3.1.4: HMGA2 suppression hampers the ESC 
differentiation. A) ESCs transfected with siHMGA2 were 
differentiated into SFEBs. Oct4 and Otx2 expression profile was 
evaluated by Western Blot analysis at 2 and 4 days in SFEBs KD 
HMGA2. B) Rex1 and Klf4 mRNA levels measured by q-PCR in 
EpiSCs derived from HMGA2 silenced cells compared to the control 
(siCTRL).  
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3.2 Hmga2 is necessary to mESCs differentiation into EpiSCs 
 
            To explore the possibility that HMGA2 KD was interfering 
with the transition from ESCs into EpiSCs, we induced ESC 
differentiation in culture conditions that stabilizes the EpiSC state 
(Hayashi et al., and Nakaki et al 2013). Two days after the induction 
of differentiation of wt cells, Rex1 and Dax1 decreased while Fgf5, a 
specific marker of the epiblast, started to accumulate. The 
establishment of the EpiSC phenotype was also characterized by the 
decrease of Oct4 and Nanog and by the accumulation of Otx2 
(Acampora, 2013). The silencing of HMGA2 altered this 
differentiation phenotype. Indeed, Fgf5 levels were lower in KD cells 
compared to wt cells, while Oct4 and Nanog continued to be 
expressed at high levels. Moreover, while Rex1 and Dax1 are actually 
undetectable in wt EpiSCs, they are still expressed in HMGA2 KD 
cells. The expression of Otx2 again was unchanged upon HMGA2 KD 
(Figure3.2.1). In summary, these results confirm the possibility that 
HMGA2 silencing is hampering the transition from ESCs into 
EpiSCs.      
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Figure 3.2.1: HMGA2 silencing hampers the transition from ESC 
to EpiSCs. siHMAG2 was transfected in ESCs and then cells were 
induced to differentiated in EpiSCs. The panels show the expression 
of stemness markers (Oct4, Nanog, Rex1 and Klf4) and a specific 
epiblast marker Fgf5. 
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However, HMGA2 knock down by RNA interference did not allow us 
to definitively address the question of whether this protein is 
necessary for the transition from ESCs into EpiSCs. This is due to the 
transient nature and to the heterogeneity of the silencing upon 
transfection with siRNA in the cells. Therefore, to easily explore the 
function of HMGA2 in the early steps of pluripotent stem cells 
differentiation, we have generated iPS cells from embryonic 
fibroblasts (MEFs) derived from HMGA2 knock out embryos. The 
iPS cells were obtained by over-expressing OCT3/4, Sox2 and Klf4 
using retroviral infection as previously reported (Nakagawa et al., 
2007). The HMGA2 KO iPS cells appeared to be not distinguishable 
from the wt iPS cells with a normal pattern of expression of 
pluripotency markers. However, when these cells were induced to 
differentiate into neuroectoderm through SFEB formation, a dramatic 
phenotype appeared, characterized by an almost complete block of 
differentiation. As shown in figure3.2.2A,  in contrast with the high 
number of Sox1 positive cells observed in differentiated wild type iPS 
cells, almost all the HMGA2 KO cells remained positive for Oct4, 
with only very few cells expressing Sox1. To confirm that the block of 
differentiation due to the absence of HMGA2 occurs soon after the 
differentiation induction, that is when undifferentiated iPS clones 
become EpiSCs, we induced EpiSC formation of several and 
independent the iPS clones. We have found that the HMGA2 KO 
clones shows an evident inability to develop into EpiSCs (Figure 
3.2.2B). All together, these results demonstrated that HMGA2 is 
necessary in vitro for the transition from undifferentiated ESCs/iPS 
cells into EpiSCs. 
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                                                             Results 
 
28 
 
 
B) 
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Figure 3.2.2: HMGA2 is necessary for the transition from ESC to 
EpiSCs. A) Immunostaining of a representative iPS HMGA2 KO 
clone generated from KO HMGA2 MEFs compared with iPS wild 
type after 4d of SFEB differentiation for the presence of stemness 
(Oct4) and neuroectoderm (Sox1) markers; B) several and 
independent iPS cell clones were differentiated into EpiSCs and then 
the expression levels of stemness (Oct4 and Nanog) and epiblast 
marker Fgf5 were analyzed.  
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3.3 HMGA2 gene expression is regulated by Otx2 
 
             Several papers have recently reported that Oct4 and Otx2 
transcription factors play a crucial role in the regulation of ESC 
differentiation from the undifferentiated stem cell state into the post-
implantation epiblast state (Acampora, 2013, Buecker, 2014, Yang, 
2014). These results prompted us to examine the possibility the 
HMGA2 is under the control of these transcription factors. As 
reported above, HMGA2 accumulates upon the induction of ESC 
differentiation (Figure 3.1.3). We first asked whether the suppression 
of Otx2 or of Oct4 alters the expression profile of HMGA2 in ESCs. 
As shown in figure 3.3.1, HMGA2 protein was undetectable in both 
wt and Otx2 KO ESCs, while it was about 50% lower in Otx2 KO 
ESCs induced to differentiate into SFEBs. The HMGA2 mRNA 
showed the same behaviour of the cognate protein. On the contrary, 
HMGA2 mRNA significantly increased in undifferentiated Oct4 KD 
cells and the protein was about two-fold higher in Oct4 KD cells vs wt 
cells, upon the induction of differentiation. These results suggested 
that HMGA2 may be a direct target of Otx2 and Oct4. To explore this 
possibility, we examined the already published ChIP-seq data and we 
found that the HMGA2 gene is one of the candidate targets of both 
Otx2 and Oct4 in EpiSCs. Inspection of the DNA sequence, where 
Otx2 and Oct4 binding take place, demonstrated the presence of two 
bona fide cis-elements for these transcription factors. Thus, we 
analyzed the direct binding of Otx2 and of Oct4 to HMGA2 promoter 
by ChIP-qPCR in undifferentiated ESCs and in EpiSCs. We observed 
a significant interaction of Oct4 with the HMGA2 promoter in ESCs 
while in EpiSCs the binding of Otx2 and, to a lesser extent of Oct4, 
was very evident (Figure 3.3.2). Based on these data, we suggest that 
Oct4 and Otx2 may control HMGA2 expression during ESC 
differentiation in a negative and positive manner, respectively.  
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Figure 3.3.1: HMGA2 is a direct target of Oct4 and Otx2. Changes 
of HMGA2 expression levels were analyzed in ESC and in 4d SFEBs 
derived from Otx2 KO cells and Oct4 silenced cells by Western Blot 
and RT-PCR analysis. 
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                                      HMGA2 promoter 
 
 
                                      HMGA2 promoter 
 
 
 
 
 
Figure 3.3.2. Oct4 and Otx2 control HMGA2 expression during 
ESCs differentiation. ChIP experiments were performed in wild tipe 
ESCs and EpiSCs to evaluate the Oct4 and Otx2 binding to HMGA2 
promoter. 
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3.4 HMGA2 role in the control of Oct4 expression 
 
             As reported above, HMGA2 suppression hampers the 
formation of EpiSCs. In these conditions, the expression levels of 
Oct4 were maintained high by the suppression of HMGA2, while no 
changes were observed in the expression of Otx2, which accumulated 
to the same extent observed in wt cells. Thus, we asked whether 
HMGA2 directly regulates Oct4. Oct4 gene promoter is governed by 
an auto-regulatory loop, as it activates the transcription of its own 
gene, together with Sox2 and Nanog (Boyer et al., 2005). The results 
of ChIP experiments reported in Figure 3.4.1A showed that, as 
expected, Oct4 was associated with its promoter in ESCs. The extent 
of this binding slightly decreased in EpiSCs after the induction of 
differentiation. The same chromatin preparations used to analyze the 
binding of Oct4 were immune-precipitated with a HMGA2 antibody. 
We carried out the scanning of the genomic region upstream of the 
TSSs of the Oct4. While in ESCs no significant binding for HMGA2 
was found, in agreement with the observation that HMGA2 is 
undetectable in these cells, HMGA2 antibody efficiently pulled down 
specific regions of Oct4 gene promoter in EpiSCs. (Figure 3.4.1B). 
The effects of HMGA2 on the transcription of Oct4 were examined by 
measuring the luciferase reporter transcription under the control of 
Oct4 promoter. The results shown in Figure 3.4.2 demonstrated that 
luciferase expression is significantly decrease in the cells where 
HMGA2 was overexpressed. These results indicate that HMGA2 is 
associated with Oct4 promoter and its binding parallels the down-
regulation of Oct4 gene transcription, thus suggesting a repressor role 
for HMGA2 on these gene. 
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Oct4 promoter in ESCs and EpiSCs 
 
A)             
 
B) 
 
 
 
 
Figure 3.4.1: HMGA2 affects Oct4 transcription binding its 
promoter. A) ChIP experiment of Oct4 binding on its own promoter 
in ESCs and EpiSCs. B) HMGA2 binding on Oct4 promoter was 
examined by ChIP using the same chromatin preparation of anti Oct4-
ChIP in A). 
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Figure 3.4.2: HMGA2 down-regulate Oct4 expression. Luciferase 
reporter cloned under control of Oct4 gene promoter was transfected 
in ESCs-Hmga2 overexpression resulted in a decrease of luciferase 
activity. 
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4. Discussion/Conclusions 
 
              ESCs derive from the inner cell mass of pre-implantation 
embryo and have the ability to self-renew in culture and to 
differentiate giving rise to all specialized cell types of the embryo. For 
these characteristics, they represent a powerful tool for the  study of 
the development and for experimental medicine. For these reasons the 
complete understanding of the mechanisms underlying ESC decisions 
is necessary to provide new ESC-based developmental models and for 
clinical applications of these cells. A complex balance between 
different signals tightly regulates ESC state. All these signals 
converge on a complex transcriptional network that in turn regulates 
gene expression.  
               In the recent years, the regulatory mechanism that control the 
maintenance of pluripotent state has been extensively investigated. 
Indeed, many of the transcription factors (TF) involved in the 
establishment and in the maintenance of pluripotency are well 
characterized. Among these TFs there are Oct4 and Sox2, necessary to 
establish and maintain pluripotency (Niwa et al., 2000; Masui et al., 
2007), Nanog, required to establish but not to maintain the ESC naïve 
state (Boyer et al., 2005), and several other TFs, like Klf2, Klf4, Klf5, 
Sall4, Gbx2, Tbx3, Essrb, etc, whose silencing severely affects ESC 
state. These factors and many others are interconnected in a complex 
network of reciprocal regulation, and even slight alterations of their 
concentration often perturb pluripotency and differentiation. 
              Few years ago, the laboratory of Prof. Russo undertook a 
project to identified factors governing ESC fate through a screening of 
a shRNA library. The work done during my doctoral thesis was aimed 
to analyze the effects of the suppression of a non-histonic chromatin 
factor HMGA2, identified through this screening, on ESC fate. 
HMGA2  along with other members of HMGA family, contains three 
N-terminal AT-hook motifs through which it binds preferentially to 
AT-rich sequences, and induces conformational changes to promote 
the recruitment of transcription factors to specific complexes. It lacks 
a transcriptional activity per se, but acts by orchestrating the assembly 
of transcription factor complexes also known as enhanceosome, thus 
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resulting in positive or negative regulation of gene expression (Wolffe 
et al., 1994; Ashar et al., 2010). The high expression of HMGA 
proteins during embryogenesis suggests that they fulfill important 
roles in development. However, the physiological role of HMGA 
factors in the early steps of development is still unknown as well as 
the transcription regulatory mechanisms they are involved in. We have 
demonstrated that, in condition promoting differentiation HMGA2 
suppression maintains the undifferentiated phenotype, preventing 
ESCs transition into EpiSCs. A detailed analysis of the early steps of 
ESC differentiation, using HMGA2 KO iPS clones, gave the same 
results but with a more dramatic phenotype. 
            A recent paper reported HMGA2 as a putative target of Otx2 
and Oct4 on the basis of ChIP-seq data (Yang et al., 2014). We have 
found that the expression of HMGA2 is regulated by Otx2 and Oct4 
but while Otx2 promotes the expression of Hmga2, Oct4 acts as a 
suppressor. We have also demonstrated through ChIP experiment that 
a cis element in proximity of HMGA2 TSS interacts with Otx2 and 
Oct4 to regulate HMGA2 expression. Interestingly, we have also 
found that Hmga2 negatively regulates the expression of Oct4 gene 
during differentiation by directly binding to the regulatory region of 
its promoter. Finally, all together these results demonstrate that 
HMGA2 plays a crucial role in ESC fate determination, allowing the 
changes of gene expression program that lead ESCs to the exit from 
ground state.  
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